Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043783113> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2043783113 endingPage "548" @default.
- W2043783113 startingPage "543" @default.
- W2043783113 abstract "The topoisomerase-1 inhibitor, topotecan, is an established chemotherapy agent for the treatment of relapsed ovarian cancer after the failure of platinum-based chemotherapy, and is an established treatment choice at first relapse. In line with National Institute for Clinical Excellence (NICE) guidance, topotecan has been used at Nottingham City Hospital for the last 2 years.A retrospective audit, over the period September 2001 to September 2002, was carried out to assess response rates and side-effects for patients with relapsed ovarian cancer who were treated with topotecan. Twenty-five patients received topotecan as a 30-min intravenous infusion for 5 consecutive days, every 21 days. The starting dose was either 1.5 mg/m2/day (n = 22) or 1.25 mg/m2/day (n = 3). Patient response was monitored by physical examination and serological CA125 tumour marker level. Radiological assessment was by computed tomography.Eighteen (72%) patients had their previous platinum-based treatment less than 6 months before topotecan therapy. Thirteen patients received topotecan therapy as second-line, seven as third-line and five as > or = fourth-line treatment. Twenty-two (88%) patients who received more than one cycle of chemotherapy were evaluable for response. A clinical benefit was observed in 11 (44%) patients (two [8%] partial response and nine [36%] stable disease). Seven patients achieving clinical benefit received topotecan as second-line treatment. Dose was reduced from 1.5 to 1.25 mg/m2/day in six patients after the first cycle of topotecan. Twelve (48%) patients had dose delay of at least 1 week. Grade 3/4 neutropenia, observed in nine (36%) patients, was the main dose-limiting toxicity. One patient died as a result of treatment.The Nottingham experience with topotecan in platinum-resistant ovarian cancer has been encouraging, even in such a heavily pre-treated patient population. There is a better chance of response if the patients receive topotecan at first relapse. The haematological toxicity is significant but manageable with dose reduction and dose delay." @default.
- W2043783113 created "2016-06-24" @default.
- W2043783113 creator A5031499770 @default.
- W2043783113 creator A5056848636 @default.
- W2043783113 date "2004-12-01" @default.
- W2043783113 modified "2023-09-24" @default.
- W2043783113 title "The use of topotecan for relapsed ovarian cancer in accordance with the National Institute for Clinical Excellence guidance 2001: the Nottingham experience" @default.
- W2043783113 cites W1522554466 @default.
- W2043783113 cites W1579641819 @default.
- W2043783113 cites W1853779534 @default.
- W2043783113 cites W1913802169 @default.
- W2043783113 cites W1935237200 @default.
- W2043783113 cites W1960327677 @default.
- W2043783113 cites W1979355909 @default.
- W2043783113 cites W2006628454 @default.
- W2043783113 cites W2028269517 @default.
- W2043783113 cites W2029744419 @default.
- W2043783113 cites W2073037820 @default.
- W2043783113 cites W2094928529 @default.
- W2043783113 cites W2097105130 @default.
- W2043783113 cites W2099650890 @default.
- W2043783113 cites W2141722396 @default.
- W2043783113 cites W2167805334 @default.
- W2043783113 cites W2222529560 @default.
- W2043783113 cites W2267902670 @default.
- W2043783113 cites W2328421677 @default.
- W2043783113 cites W2405738366 @default.
- W2043783113 cites W2419560340 @default.
- W2043783113 cites W2419662317 @default.
- W2043783113 doi "https://doi.org/10.1016/j.clon.2004.07.003" @default.
- W2043783113 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15630848" @default.
- W2043783113 hasPublicationYear "2004" @default.
- W2043783113 type Work @default.
- W2043783113 sameAs 2043783113 @default.
- W2043783113 citedByCount "2" @default.
- W2043783113 crossrefType "journal-article" @default.
- W2043783113 hasAuthorship W2043783113A5031499770 @default.
- W2043783113 hasAuthorship W2043783113A5056848636 @default.
- W2043783113 hasConcept C121608353 @default.
- W2043783113 hasConcept C126322002 @default.
- W2043783113 hasConcept C141071460 @default.
- W2043783113 hasConcept C143998085 @default.
- W2043783113 hasConcept C2776694085 @default.
- W2043783113 hasConcept C2780259306 @default.
- W2043783113 hasConcept C2780427987 @default.
- W2043783113 hasConcept C2781209748 @default.
- W2043783113 hasConcept C526805850 @default.
- W2043783113 hasConcept C71924100 @default.
- W2043783113 hasConceptScore W2043783113C121608353 @default.
- W2043783113 hasConceptScore W2043783113C126322002 @default.
- W2043783113 hasConceptScore W2043783113C141071460 @default.
- W2043783113 hasConceptScore W2043783113C143998085 @default.
- W2043783113 hasConceptScore W2043783113C2776694085 @default.
- W2043783113 hasConceptScore W2043783113C2780259306 @default.
- W2043783113 hasConceptScore W2043783113C2780427987 @default.
- W2043783113 hasConceptScore W2043783113C2781209748 @default.
- W2043783113 hasConceptScore W2043783113C526805850 @default.
- W2043783113 hasConceptScore W2043783113C71924100 @default.
- W2043783113 hasIssue "8" @default.
- W2043783113 hasLocation W20437831131 @default.
- W2043783113 hasLocation W20437831132 @default.
- W2043783113 hasOpenAccess W2043783113 @default.
- W2043783113 hasPrimaryLocation W20437831131 @default.
- W2043783113 hasRelatedWork W2029415824 @default.
- W2043783113 hasRelatedWork W2081099381 @default.
- W2043783113 hasRelatedWork W2124273755 @default.
- W2043783113 hasRelatedWork W2349518346 @default.
- W2043783113 hasRelatedWork W2385947617 @default.
- W2043783113 hasRelatedWork W2466209479 @default.
- W2043783113 hasRelatedWork W2471957740 @default.
- W2043783113 hasRelatedWork W2536486074 @default.
- W2043783113 hasRelatedWork W2547508429 @default.
- W2043783113 hasRelatedWork W2559759225 @default.
- W2043783113 hasVolume "16" @default.
- W2043783113 isParatext "false" @default.
- W2043783113 isRetracted "false" @default.
- W2043783113 magId "2043783113" @default.
- W2043783113 workType "article" @default.